Fengyan Xu

5PUBLICATIONS
8CO-AUTHORS
PharmacogenomicsEpidemiological modellingComputational methods in fluid flow, heat and mass transfer (incl. computational fluid dynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 31, 2026
Population Pharmacokinetics of Serplulimab and Quantitative Assessment of Transitioning From Weight-Based to Flat-Dosing Strategy.

Kun Wang, Yuanyuan Shen, Chen Hu

|Feb 26, 2026
Model-Informed Dosing Regimen of Sugemalimab for European Patients With Non-Small Cell Lung Cancer: Bridging From Asian Clinical Data.

Yucheng Sheng, Zenglian Yue, Fengyan Xu

|Sep 11, 2025
Population Pharmacokinetics and Exposure-Response Analysis of Serplulimab in Small Cell Lung Cancer Patients.

Kun Wang, Yuanyuan Shen, Chen Hu

|Apr 26, 2025
Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model-Based Approach.

Ahsan Rizwan, Hugh Giovinazzo, Tian Yu

|Oct 10, 2024
Comprehensive population pharmacokinetic modelling of sugemalimab, an anti-programmed death-ligand 1 (PD-L1) human monoclonal antibody, in patients with solid tumours or lymphomas across multiple Phase I-III studies.

Kun Wang, Chaohsuan Pan, Fengyan Xu

Pageof 1

Frequent Collaborators

4 joint publications

Kun Wang

3 joint publications

Yuying Gao

2 joint publications

Yucheng Sheng

1 joint publications

Chaohsuan Pan